The Planet Dog Foundation (PDF) strives to support worthy organizations through a grant-making program designed to financially support 501(c)(3) not-for-profit partners nationwide. The goal of our grant program is to fund new and proven initiatives that bring people and pets together for mutual benefit and support.Funding is allocated nationwide to promote and financially support service-oriented canine programs. Service-oriented canine programs include the following:
*service dogs *therapy dogs *animal assisted therapy *search and rescue dogs *police, fire, military dogs *other innovative canine service programs IMPORTANT NOTE: ALTHOUGH WE VALUE AND RESPECT THE HARD WORK OF SPAY/NEUTER PROGRAMS, ANIMAL SHELTERS AND RESCUE PROGRAMS, UNFORTUNATELY THEY ARE OUT OF THE SCOPE OF OUR GRANT-GIVING GUIDELINES.WE DO NOT FUND ANY PROGRAMS ENGAGED IN ANIMAL CRUELTY OR TESTING.PDF Giving GuidelinesAs a small company doing big things, we are looking to support like-minded organizations that will most benefit from our support. As our grants do not exceed $10,000, we will be reviewing annual operational budgets to fund those organizations best able to maximize a PDF grant.PDF giving will be allocated in two funding streams annually. The Planet Dog Foundation funds only organizations classified as tax-exempt under section 501(c) (3) of the Internal Revenue Service.We do not fund the following: *Spay/Neuter Programs *Adoption Shelters Operating Expenses *Rescue Program Operating Expenses *Individuals *Political Groups *Religious Groups (or groups with any religious affiliation) *For-profit organizations *Scholarship Programs *Government Agencies *Non-profit agencies with any determination other than 501(C)(3) *Programs spending more than 35% of expenses on administrative costs *Any program engaged in animal testing or animal cruelty. Application Guidelines & Deadlines:PDF awards grants twice annually. Applications begin with the submission of a formal letter of intent.After review, Planet Dog Foundation staff will contact those organizations who are invited to submit additional materials to complete a full proposal.Before submitting a letter of intent, be sure you have reviewed our grant-making goals and the list of organizations we do not fund. Ineligible organizations will not be invited to complete a full proposal.Spring Cycle: Letters of Intent MUST be received by February 15, 2008.Fall Cycle: Letters of Intent MUST be received by August 1, 2008.Due to the volume of materials received by the Planet Dog Foundation, we cannot return any submitted items.We look forward to hearing about your programs. We thank you for the work that you do helping dogs to help people. Please do not hesitate to contact the Executive Director to discuss your programs, your proposal or our work.
Planet Dog Foundation, 49 York St, Portland, ME 04101 | pdf@planetdog.com | 207.761.1515
Program Description The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments. The Clinical Investigator Award responds to three recognized realities: Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation. The Damon Runyon Cancer Research Foundation's award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee. Building on the long-term success of the Damon Runyon Postdoctoral Fellowships, the creation of the Clinical Investigator Award is a logical extension of the Foundation's overall mission to defeat cancer. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators. Program Sponsors Eli Lilly and Company is the founding sponsor of the Clinical Investigator Award and continues to generously support the program in addition to Siemens Medical Solutions, Novartis and Genentech. In light of the Foundation's partnership with Siemens Medical Solutions, in addition to candidates working in translational clinical oncology, the Foundation is interested in candidates whose research relates to or uses imaging technologies and molecular imaging in cancer. Definition of Clinical Research For the purposes of this award, the Foundation's definition of clinical research will follow the definition set out in "The NIH Director's Panel on Clinical Research Report to The Advisory Committee to The NIH Director," December, 1997. (a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers. (b) Epidemiologic and behavioral studies. (c) Outcomes research and health services research. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived. Preference will be given to research that adheres to the "Handshake Rule," meaning that the physician will meet each patient in their research studies. Eligibility 1) The applicant must be a U.S. citizen or permanent legal resident. 2) Each applicant must be nominated by their institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation. Only two (2) nominations per institution, including its affiliated schools, will be accepted. 3) The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible. 4)The applicant may apply during the final year of their subspecialty training or within the first four years of their initial assistant professorship appointment. Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply. 5) The applicant must commit to spending 80% of their time conducting research. 6)The applicant is required to apply in conjunction with a mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time. Research, Training and Development During each year of the award, the applicant must commit a minimum of 80% of their full-time professional effort to the conduct of research and research career development. The Mentor's role is to foster the development of the applicant's knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels. Funding The Award will be for a period of three years. Funding in the amounts presented in the table below will be allocated to the awardee's institution for the specific support of the Clinical Investigator. No part of this award can be used for indirect costs or institutional overhead. Year Awardee Stipend Research Allowance 1 $100,000 $50,000 2 $100,000 $50,000 3 $100,000 $50,000 A portion of the stipend may be applied to research costs upon request. Other Funding: Investigators may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award. Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g. K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed. Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to): American Cancer Society - Mentored Research Scholar Grant in Applied and Clinical Research ASCO - Career Development Award Burroughs Wellcome Fund - Clinical Scientist Award in Translational Research - Career Awards for Medical Scientists (CAMS) Doris Duke Charitable Foundation - Clinical Scientist Development Award Howard Hughes Medical Institute - Physician-Scientist Early Career Award Kimmel Foundation - Kimmel Translational Science Award Leukemia and Lymphoma Society - Career Development Program Please contact the Foundation with any questions regarding concurrent funding (212-455-0520). Debt Repayment Program: The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.
Selection and Review Selection: The Clinical Investigator Award Committee (CIAC) will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation's Board of Directors. CIAC puts a premium on innovation and creativity when reviewing applications. Selection Criteria Excellence of the applicant and mentor. Innovation, creativity, quality and originality of the research proposal. The commitment of the mentor and institution to the development and training of the applicant as an independent clinical research investigator. Evidence of the applicant's commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems. Importance of the proposed research to the field of cancer and/or cancer prevention. All application materials should be submitted to the Damon Runyon Cancer Research Foundation for arrival at our offices on or before the March 2 deadline.
Award Programs Damon Runyon Cancer Research Foundation One Exchange Plaza 55 Broadway, Suite 302 New York, NY 10006 (212)-455-0520
Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer's Research The American Academy of Neurology (AAN) Foundation and the Alzheimer's Association are pleased to announce the Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer's disease research, a two-year fellowship. The fellowship is supported by the AAN Foundation and the Alzheimer's Association.
Mailing Address Mail application materials to: AAN Foundation Attn: Terry Heinz Grants Administrator 1080 Montreal Avenue St. Paul, MN 55116
The American Academy of Neurology (AAN) Foundation is pleased to announce five two-year fellowships to support clinical research training in the neurosciences. The fellowships are supported by the AAN, the AAN Foundation, and the AAN Foundation Corporate Roundtable.
Information for Grant Applicants New Submission Deadlines for Research Grants (Effective Dec. 15, 2007) Beginning Dec. 15, 2007, the American Foundation for Suicide Prevention.will accept and review applications for all categories of research grants and fellowships two times a year, with submission deadlines of Dec. 15 and June 15. In making these changes, the AFSP Scientific Council is seeking to make the Foundation's research grant program more responsive to time-sensitive topics with high relevance for suicide research, lessen the waiting time required for applicants to resubmit promising applications, and streamline the administrative processes related to grants review. A second change approved by the Scientific Council is an increase in the grant amounts for Standard Research Grants (from a maximum of $60,000 to $75,000), Young Investigator Grants (from $70,000 to $85,000) and Pilot Grants (from $20,000 to $30,000). These changes will also go into effect beginning with the Dec. 15, 2007 cycle. Distinguished Investigator Grants and Postdoctoral Research Fellowships will remain at their current levels of $100,000.
All questions should be directed to: Tracey Auster, research administrator, at tauster@afsp.org or (212) 363-3500 Ext.15. Eligibility AFSP research grants support studies that aim to increase understanding of the causes of suicide and factors related to suicide risk, or to test treatments and other interventions designed to prevent suicide. Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, providing the study has an essential focus on suicide or suicide prevention. AFSP grants are awarded for one or two-year periods. Grant Categories AFSP offers five types of research grants: Distinguished Investigator Grants for up to $100,000 over two years are awarded to investigators at the level of associate professor or higher with an established record of research and publication on suicide. Standard Research Grants for up to $75,000 over two years are awarded to individual investigators at any level. Young Investigator Grants for up to $85,000 over two years are awarded to investigators at the level of assistant professor or lower. In addition to a maximum of $75,000 for the investigator’s research, these grants provide an additional $10,000 ($5,000 per year) for an established suicide researcher who will mentor the Young Investigator. Postdoctoral Research Fellowships for up to $100,000 over two years are awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have not had more than three years of fellowship support. Fellows receive a progressive stipend of $42,000 in the first year and $46,000 in the second, with an institutional allowance of $6,000 per year. Pilot Grants of up to $30,000 over one or two years are awarded to investigators at any level. These grants provide seed money for new projects that have the potential to lead to subsequent larger investigations.
American Foundation for Suicide Prevention 120 Wall Street, 22nd Floor New York, NY 10005 Toll-free: 1-888-333-AFSP Phone: (212) 363-3500 Fax: (212) 363-6237 Website: www.afsp.org Email: inquiry@afsp.org
123next
